Literature DB >> 31841641

Lung Function Decline in Early HIV Infection: Impact of Antiretroviral Drug Timing and Drug Regimen.

Ken M Kunisaki1,2, Jason V Baker3, Gary Collins2, David M MacDonald2, Elzbieta Bakowska4, Kamal Marhoum El Filali5, Eriobu Nnakelu6, Alberto La Rosa7, John E Connett2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31841641      PMCID： PMC7068829          DOI： 10.1164/rccm.201911-2266LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  8 in total

1.  Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era.

Authors:  Matthew R Gingo; M Patricia George; Cathy J Kessinger; Lorrie Lucht; Barbara Rissler; Renee Weinman; William A Slivka; Deborah K McMahon; Sally E Wenzel; Frank C Sciurba; Alison Morris
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

Review 2.  Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis.

Authors:  Jean Joel Bigna; Angeladine Malaha Kenne; Serra Lem Asangbeh; Aurelie T Sibetcheu
Journal:  Lancet Glob Health       Date:  2017-12-16       Impact factor: 26.763

3.  Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.

Authors:  Ken M Kunisaki; Dennis E Niewoehner; Gary Collins; Bitten Aagaard; Nafisah B Atako; Elzbieta Bakowska; Amanda Clarke; Giulio Maria Corbelli; Ernest Ekong; Sean Emery; Elizabeth B Finley; Eric Florence; Rosa M Infante; Cissy M Kityo; Juan Sierra Madero; Daniel E Nixon; Ellen Tedaldi; Jørgen Vestbo; Robin Wood; John E Connett
Journal:  Lancet Respir Med       Date:  2016-10-20       Impact factor: 30.700

4.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.

Authors:  E Prescott; A M Bjerg; P K Andersen; P Lange; J Vestbo
Journal:  Eur Respir J       Date:  1997-04       Impact factor: 16.671

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; J E Connett; R E Kanner; W W Lee; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

7.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Michael S Saag; Constance A Benson; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Michael J Mugavero; Paul E Sax; Davey M Smith; Melanie A Thompson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2018-07-24       Impact factor: 56.272

8.  Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

Authors:  M Patricia George; Mouhamed Kannass; Laurence Huang; Frank C Sciurba; Alison Morris
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240
  8 in total
  2 in total

1.  Dyspnea and Pulmonary Function Among Participants in the Multicenter AIDS Cohort Study Using Protease Inhibitors: A Cross-Sectional Study.

Authors:  Charles Terry; Christina Mehta; JaNae Holloway; Anandi Sheth; Igho Ofotokun; Alison Abraham; Ken M Kunisaki; Mallory Witt; Meredith C Mccormack; Alison Morris; Michael Bradley Drummond; Robert Jensen; Valentina Stosor; Bernard Macatangay; Sushma Cribbs
Journal:  AIDS Res Hum Retroviruses       Date:  2022-02       Impact factor: 1.723

Review 2.  Chronic obstructive pulmonary disease in HIV.

Authors:  Katerina Byanova; Ken M Kunisaki; Joshua Vasquez; Laurence Huang
Journal:  Expert Rev Respir Med       Date:  2020-11-23       Impact factor: 3.772
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.